SCULPTWEAR Trademark

Trademark Overview


On Thursday, September 26, 2024, a trademark application was filed for SCULPTWEAR with the United States Patent and Trademark Office. The USPTO has given the SCULPTWEAR trademark a serial number of 98771068. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, April 2, 2025. This trademark is owned by Clinique Laboratories, LLC. The SCULPTWEAR trademark is filed in the Cosmetics & Cleaning Products category with the following description:

Cosmetics; Non-medicated skin care preparations
sculptwear

General Information


Serial Number98771068
Word MarkSCULPTWEAR
Filing DateThursday, September 26, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, April 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkSCULPT WEAR
Goods and ServicesCosmetics; Non-medicated skin care preparations

Classification Information


International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 26, 2024
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameClinique Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10153

Trademark Events


Event DateEvent Description
Thursday, September 26, 2024NEW APPLICATION ENTERED
Tuesday, April 1, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 2, 2025ASSIGNED TO EXAMINER
Wednesday, April 2, 2025NON-FINAL ACTION WRITTEN
Wednesday, April 2, 2025NON-FINAL ACTION E-MAILED
Wednesday, April 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED